The DIABLO Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells, engineered for targeted disruption of the DIABLO gene (also known as SMAC). This loss-of-function model provides a robust tool for dissecting apoptotic signaling cascades in a human cellular context. The polyclonal format ensures a diverse pool of edited cells, minimizing clonal selection artifacts while maintaining the growth characteristics and transfection efficiency of the parental line. Researchers can rely on this product for reproducible and physiologically relevant studies of programmed cell death.
The host cell line, HEK293T, is an immortalized human embryonic kidney cell line that stably expresses the SV40 large T antigen. This modification allows for episomal replication of plasmids and significantly enhances protein expression, making HEK293T a preferred system for a wide range of molecular biology and biochemistry applications. Its robust growth, ease of transfection, and well-characterized signaling pathways establish it as an ideal background for generating CRISPR-based knockout models. The DIABLO disruption in these cells thus combines the advantages of the HEK293T platform with a specific genetic perturbation relevant to apoptosis research.
DIABLO is a mitochondrial protein that functions as a key promoter of apoptosis. Upon receiving apoptotic stimuli such as DNA damage, UV radiation, or activation of death receptors by ligands like FAS ligand, TRAIL, or TNF-alpha, DIABLO is released into the cytosol. There, it binds to inhibitor of apoptosis proteins (IAPs) including XIAP, cIAP1, and cIAP2, thereby blocking their ability to inhibit caspases. This relief of inhibition facilitates the activation of caspase-9, caspase-3, and caspase-7. Mechanistically, DIABLO acts downstream of cytochrome c and APAF1 in the intrinsic pathway and also participates in crosstalk with the extrinsic pathway, ensuring effective execution of apoptotic cell death.
In the HEK293T background, knocking out DIABLO disrupts a critical node in the apoptotic network, allowing researchers to investigate how cells respond to pro-death signals in its absence. This model is particularly useful for exploring mechanisms of apoptosis evasion, a hallmark of cancer, and for evaluating how chemotherapeutic agents or targeted therapies might overcome resistance. By eliminating DIABLO function, the cells can reveal compensatory survival pathways mediated by IAPs or other factors, and they serve as a valuable comparator in mitochondrial dysfunction studies. The model thus provides a clear genetic context to assess the dependency of cell death on DIABLO-mediated IAP neutralization.
This polyclonal knockout cell population is well-suited for a variety of research applications, including mechanistic studies of apoptosis regulation, cancer cell survival, and drug discovery targeting the IAP family. Typical downstream assays include western blotting for cleaved caspases, annexin V/PI flow cytometry to quantify apoptosis, caspase activity assays, cytochrome c release assays, RT-qPCR for apoptosis-related genes, and immunofluorescence for DIABLO and cytochrome c localization. The cells also enable screening of IAP antagonists and investigation of mitochondrial integrity under stress conditions. For additional information or customized solutions, please contact Ascent Research.
